Skip to main content

Table 4 Changes in Cardiopulmonary Exercise Tests

From: Vitamin D3 repletion versus placebo as adjunctive treatment of heart failure patient quality of life and hormonal indices: a randomized, double-blind, placebo-controlled trial

  Vitamin D Placebo p-value Corrected model p-value Vitamin D CI (lower) Vitamin D CI (higher)
Peak VO2 ml/kg/min −1.7 ± 3.4 0.4 ± 3.5 0.12 0.30 −3.2 −0.21
Peak METS −0.5 ± 1.1 −0.2 ± 0.7 0.43 0.32 −0.9 0.03
Peak Tidal Vol 30 ± 380 −40 ± 240 0.55 0.72 −132.5 195.3
CRI 0.1 ± 0.20 0 ± 2.9 0.009* 0.17 0.02 0.24
VE Slope 3.0 ± 6.7 0.8 ± 5.7 0.36 0.51 0.1 5.9
Heart Composite 0.3 ± 0.7 0.1 ± 0.6 0.32 0.57 0.28 0.36
Pulmonary Vascular Score 0.1 ± 0.5 0.1 ± 0.6 0.97 0.34 −0.1 0.4
Deconditioning Score 0.3 ± 0.6 0.2 ± 0.7 0.65 0.19 0.03 0.53
PETCO2(mmHg) −1.6 ± 3.4 −0.6 ± 1.9 0.30 0.40 −3.1 −0.11
Shape Score 0.1 ± 1.6 0.3 ± 1.0 0.65 0.71 −0.6 0.8
Peak RER 0.1 ± 0.3 −0 ± 0.1 0.26 0.44 0 0.24
OUES −0.1 ± 0.4 −0.3 ± 0.5 0.12 0.32 −0.14 0.36
  1. Data are expressed as Δ ± SD, 95% CI)
  2. Abbreviations: Standard Deviation (SD), Confidence Interval (CI), Volume of oxygen consumed (VO 2 ), metabolic equivalents (METS), volume (Vol), Ventilatory Efficiency (V E ), Respiratory Exchange Ratio (RER), Oxygen Uptake Efficiency Slope (OUES)
  3. *Using Mann-Whitney